4.6 Review

International Union of Pharmacology. LXIII. Retinoid X receptors

期刊

PHARMACOLOGICAL REVIEWS
卷 58, 期 4, 页码 760-772

出版社

AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
DOI: 10.1124/pr.58.4.7

关键词

-

资金

  1. Howard Hughes Medical Institute Funding Source: Medline
  2. NHLBI NIH HHS [R01 HL105278] Funding Source: Medline
  3. NIDDK NIH HHS [U19 DK062434, R37 DK057978] Funding Source: Medline
  4. NIEHS NIH HHS [P42 ES010337] Funding Source: Medline

向作者/读者索取更多资源

The physiological effects of retinoic acids (RAs) are mediated by members of two families of nuclear receptors, the retinoic acid receptors (RARs) and the retinoid X receptors (RXRs), which are encoded by three distinct human genes, RXR alpha, RXR beta, and RXR gamma. RARs bind both all-trans- and 9-cis-RA, whereas only the 9-cis-RA stereoisomer binds to RXRs. As RXR/RAR heterodimers, these receptors control the transcription of RA target genes through binding to RA-response elements. This review is focused on the structure, mode of action, ligands, expression, and pharmacology of RXRs. Given their role as common partners to many other members of the nuclear receptor superfamily, these receptors have been the subject of intense scrutiny. Moreover, and despite numerous studies since their initial discovery, RXRs remain enigmatic nuclear receptors, and there is still no consensus regarding their role. Indeed, multiple questions about the actual biological role of RXRs and the existence of an endogenous ligand have still to be answered.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据